Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT Pathway

被引:38
|
作者
Wang, Feixue [1 ,2 ]
Zhang, Xiang [1 ,2 ]
Liu, Weixin [1 ,2 ]
Zhou, Yunfei [1 ,2 ]
Wei, Wenchao [1 ,2 ]
Liu, Dabin [1 ,2 ]
Wong, Chi Chun [1 ,2 ]
Sung, Joseph J. Y. [1 ,2 ,3 ]
Yu, Jun [1 ,2 ]
机构
[1] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Li Ka Shing Inst Hlth Sci,CUHK Shenzhen Res Inst, Hong Kong, Peoples R China
[3] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
关键词
Nonalcoholic Steatohepatitis; Natural Killer Cell; Cytokine; JAK/STAT; FATTY LIVER-DISEASE; HEPATIC INFLAMMATION; T-CELLS; PATHOGENESIS; ORGAN; TUMORIGENESIS; CYTOKINE; DIETARY; MODEL; TNF;
D O I
10.1016/j.jcmgh.2021.08.019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Hepatic immune microenvironment plays a pivotal role in the development of nonalcoholic steatohepatitis (NASH). However, the role of natural killer (NK) cells, accounting for 10%-20% of liver lymphocytes, in NASH is still unclear. In this study, we aim to investigate the functional significance of NK cells in NASH evolution. METHODS: NASH was induced in mice fed methionine- and choline-deficient diet (MCD), choline-deficient high-fat diet (CDHFD), or high-fat diet with streptozotocin injection (STAM model). NK cell deficient mice (Nfil3(-/-)) and neutralization antibody (PK136) were used in this study. RESULTS: Activated liver NK cells were identified with increased expression of NKG2D, CD107a, and interferon- gamma but decreased inhibitory NKG2A. With NK cell deficiency Nfil3(-/-) mice, the absence of NK cells ameliorated both MCD- and CDHF-induced NASH development with significantly decreased hepatic triglycerides, peroxides, alanine aminotransferase, and aspartate aminotransferase compared with Nfil3(+/+) mice. Further molecular analysis unveiled suppressed proinflammatory cytokines and associated signaling. Mechanistically, NK cells isolated from NASH liver secreted higher levels of pro-inflammatory cytokines (interferon-gamma, interleukin 1 beta, interleukin 12, CCL4, CCL5, and granulocyte-macrophage colony-stimulating factor), which could activate hepatic JAK-STAT1/3 and nuclear factor kappa B signaling and induce hepatocyte damage evidenced by elevated reactive oxygen species and apoptosis rate. Moreover, neutralization antibody PK136-dependent NK cell depletion can significantly alleviate MCD-induced steatohepatitis with suppressed cytokine levels and JAK-STAT1/3 activity. CONCLUSIONS: NK cells in NASH liver are activated with a more pro-inflammatory cytokine milieu and promote NASH development via cytokine-JAK-STAT1/3 axis. Modulation of NK cells provides a potential therapeutic strategy for NASH.
引用
收藏
页码:257 / 274
页数:18
相关论文
共 50 条
  • [41] Upregulation of the JAK-STAT pathway promotes maturation of human embryonic stem cell-derived cardiomyocytes
    Ho, Beatrice Xuan
    Yu, Hongbing
    Pang, Jeremy Kah Sheng
    Hor, Jin-Hui
    Liew, Lee Chuen
    Szyniarowski, Piotr
    Lim, Christina Ying Yan
    An, Omer
    Yang, Henry He
    Stewart, Colin L.
    Chan, Woon Khiong
    Ng, Shi-Yan
    Soh, Boon-Seng
    STEM CELL REPORTS, 2021, 16 (12): : 2928 - 2941
  • [42] RAB32 promotes glioma cell progression by activating the JAK/STAT3 signaling pathway
    Zhang, Sinan
    Jiang, Xudong
    Wei, Qing
    Huang, Liji
    Huang, Zhuoyan
    Zhang, Lina
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (12)
  • [43] Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders
    Shouse, Geoffrey
    Nikolaenko, Liana
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 570 - 576
  • [44] Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway
    Guo, Haohao
    Wang, Ziyang
    Yin, Keyu
    Ma, Runsheng
    Zhang, Yifei
    Yin, Fanxiang
    Li, Hongqiang
    Yin, Detao
    MOLECULAR CARCINOGENESIS, 2024, 63 (04) : 701 - 713
  • [45] MicroRNA-125b promotes the regeneration and repair of spinal cord injury through regulation of JAK/STAT pathway
    Dai, J.
    Xu, L. -J.
    Han, G. -D.
    Sun, H. -L.
    Zhu, G. -T.
    Jiang, H. -T.
    Yu, G. -Y.
    Tang, X. -M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (03) : 582 - 589
  • [46] Interferon and cytokine signaling through the Jak-Stat pathway.
    Levy, D
    FASEB JOURNAL, 1996, 10 (06): : 2428 - 2428
  • [47] The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway
    Sun, Rui
    Fan, Huiping
    Liu, Jiayun
    Gao, Guomin
    Liu, Chengqi
    Zhang, Dong
    Ma, Weiyuan
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (08)
  • [48] Signaling through the JAK/STAT pathway, recent advances and future challenges
    Kisseleva, T
    Bhattacharya, S
    Braunstein, J
    Schindler, CW
    GENE, 2002, 285 (1-2) : 1 - 24
  • [49] Influence of roflumilast on sepsis mice through the JAK/STAT signaling pathway
    Chang, X.
    Hu, L. -F.
    Ma, X. -J.
    Yin, J.
    Liu, X. -Y.
    Li, J. -B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (03) : 1335 - 1341
  • [50] Deregulation of PRDM5 promotes cell proliferation by regulating JAK/STAT signaling pathway through SOCS1 in human lung adenocarcinoma
    Ren, Yuanyuan
    Wang, Ye
    Fang, Lijiao
    Ma, Mengchu
    Ge, Lin
    Su, Chao
    Xin, Lingbiao
    He, Jinyan
    Yang, Jie
    Liu, Xin
    CANCER MEDICINE, 2023, 12 (04): : 4568 - 4578